All posts by medical

Automated biochemistry analyzer machine benefits patients and health staff – Kuensel, Buhutan’s National Newspaper

Chimi Dema | Tsirang

Although used only a few weeks ago, the new automated biochemistry analyzer machine in Tsirang dzongkhag hospital is benefitting people.

Health officials say the new medical laboratory machine accommodates more samples and provide faster and accurate blood test results and benefits not only the patients but also technicians and other officials who conduct the test.

The hospitals laboratory officer, Tshewang Dorji, said when precise laboratory reports are produced, it helps patients to get timely medicine and better treatment. It also helps to reduce the turn around time for patients.

He also said the machine enhances service delivery as well as saves time. But a proper study needs to be conducted to understand its benefit better.

Tshewang Dorji explained that the semi-auto photometer, which the hospital used for the blood test in the past, could conduct only a few blood test compacts in a day, thus consuming more time. But with this new machine in place, the hospital collects more than 150 samples of blood in a day, accommodating about 50 at a time and taking around half an hour to produce the results.

Meanwhile, the health ministry provided the machine to nine other hospitals in the country.

The machines were installed on reagent rental system, where the ministry buys reagents from the machines company and the company bears machines cost as well as other maintenance charges.

Equipped with the facility to conduct 28 parameters of the blood test, the machine is expected to improve the diagnosis services and treatment services for patients.

Read more from the original source:
Automated biochemistry analyzer machine benefits patients and health staff - Kuensel, Buhutan's National Newspaper

This online puzzle game may find a coronavirus treatment – Fast Company

Coronavirus, which the World Health Organization has now officially labeled a pandemic, is taking a toll on communities around the world. Theres currently no cure for COVID-19, but scientists are working on drugs that could help slow its spread. Fortunately, citizens can get involved in the process.

Foldit is an online video game that challenges players to fold various proteins into shapes where they are stable. Generally, folding proteins allows scientists (and citizens) to design new proteins from scratch, but in the case of coronavirus, Foldit players are trying to design the drugs to combat it. Coronavirus has a spike protein that it uses to recognize human cells, says Brian Koepnick, a biochemist and researcher with the University of Washingtons Institute for Protein Design who has been using Foldit for protein research for six years. Foldit players are designing new protein drugs that can bind to the COVID spike and block this recognition, [which could] potentially stop the virus from infecting more cells in an individual who has already been exposed to the virus.

First released in 2008, Foldit grew out of an experimental research project developed by the University of Washingtons Center for Game Science along with the Department of Biochemistry. Foldits coronavirus puzzle is the games 1,808th ever. Playerswho can work alone or in teamsare using the games puzzle system to develop new protein structures that can be tested by biochemists in the lab for use in antiviral drugs.

In Foldit, you change the shape of a protein model to optimize your score. This score is actually a sophisticated calculation of the folds potential energy, says Koepnick, adding that professional researchers use an identical score function in their work. The coronavirus puzzles are set up such that high-scoring models have a better chance of actually binding to the target spike protein. Ultimately, high-scoring solutions are analyzed by researchers and considered for real-world use.

Since its inception, over half a million people have created accounts and played Foldit, and over 2,500 players have worked on the games coronavirus puzzles so far.

[Image: courtesy Fold.it]Seth Cooper, the games lead designer and an assistant professor at Northeasterns Khoury College of Computer Sciences, says Foldit was created because the design team figured that people could come up with better solutions than the computer could, and that itd be helpful for people to interact with the 3-D compositions of protein structures to truly understand how they function.

Though these online puzzles werent designed to necessarily address a steadily growing virus such as COVID-19, its become an efficient way to conduct research on the disease safely, at home. I think its really exciting to be able to potentially help out with something like this. . . . Its the kind of thing I think we would have hoped to be able to do [when we started out], Cooper says.

In the past, Foldit players have puzzled together successful synthetic and natural protein structuressuch as ones that helped solve the Mason-Pfizer monkey virus in 2011. Some of the players who are very good at Foldit dont have backgrounds in biochemistry, but the beauty of the games design is that it makes science accessible to laypeople, and it ultimately ends up teaching nonprofessionals a lot. (A handful of Foldit players were credited as authors in a paper Cooper and his colleagues published recently.)

According to Cooper, this solution-based crowdsourcing project is a way to put video games toward a good purpose. When people are playing games, theyre solving problems anyway, so its nice to apply that brainpower to solving problems in the real world.

Go here to read the rest:
This online puzzle game may find a coronavirus treatment - Fast Company

Youth told to promote personal hygiene amid pandemic panic – The Nation

Gujrat -A seminar on coronavirus ended here at Hafiz Hayat Campus of the University of Gujrat (UoG) on Thursday with the experts appealing to the masses not to get panicky about the pandemic and urging the youth for a proactive role in spreading awareness about personal hygiene. Later, an awareness walk was also organised at the campus. Titled A Seminar & Awareness Walk on Coronavirus the event was organized by Department of Biochemistry & Biotechnology. Vice Chancellor Prof. Dr Shabbar Atiq addressing the seminar said that there was no need to get panicky about the Coronavirus spread. What we need is better awareness about the preventive strategies and measures which mainly focus on personal hygiene. I call upon our youth to take the initiative for better awareness of the community, Dr Shabbar Atiq said. Pro Vice Chancellor Prof. Dr Muhammad Faheem Malik said that the pandemic panic of Coronavirus has gripped the world nations. As a Muslim nation, we have a firm belief in our faith that by following the core principles of Islam we can overcome any pandemic disease and keep ourselves out of harms way. Dr Shahzad Hussain Shah in his lecture Coronavirus Awareness said that the disease had affected as many as 70,000 people in 114 countries and caused 4630 deaths. He said that no vaccine had yet been discovered against the pandemic. He said that only preventive measures which include treatment in quarantine or isolation for those afflicted with the disease. Dr Muhammad Rehan Saeed of Nawaz Sharif Medical College (NSMC-UoG) discussed in detail the importance of personal hygiene, avoiding unnecessary hand-shake with strangers and keeping a safe distance from the suspected patients. Chairperson Biochemistry & Biotechnology Dr Nadia Zeeshan thanked the participants, especially Dr Hammad Ismail and Dr Shahzad Hussain Shah for coordinating the seminar and the walk.

Read the original here:
Youth told to promote personal hygiene amid pandemic panic - The Nation

Johns Hopkins invites 1922 applicants to join Class of 2024 – The Hub at Johns Hopkins

ByHub staff report

Johns Hopkins University invited 1,922 new students today to join the Class of 2024, which was selected from an applicant pool of 27,256. They'll join the 682 early decision students who were offered admission in December.

The Hopkins Class of 2024 comes from 49 U.S. states, the District of Columbia, Puerto Rico, and 41 other countries, including most prominently China, Canada, South Korea, and India.

The Class of 2024 have already demonstrated exceptional academic and personal excellence. Among those offered admission is the CEO of a nonprofit that has raised over $30,000 in scholarship funding to support and empower female aspiring scientists; the cofounder of a magazine for budding high school journalists; a scholar whose research focuses on the ideological strategies used by ISIS to recruit women, and whose findings were shared at a United Nations conference; and the inventor of QuitPuff, a simple test to assess early risk of oral and pre-oral cancer, which won a third grand prize biochemistry award at the International Science and Engineering Fair.

Students who applied regular decision can view admissions decisions online at mydecision.jhu.edu. Notifications were sent out at 3 p.m. today.

Admitted students have until May 1 to accept their spot in the class.

Read the original post:
Johns Hopkins invites 1922 applicants to join Class of 2024 - The Hub at Johns Hopkins

Rochester biotech company testing compound to treat coronavirus – WXXI News

A Rochester company is working on finding a treatment for coronavirus.

The biotech company OyaGen has been working with a compound called OYA1 that they say could treat coronavirus in a new way.

Rather than a vaccine, the compound works by preventing the virus from making copies of itself and spreading to other cells.

The compound has only been tested in a laboratory setting, and has not been peer-reviewed.

It's possible that it could take anywhere from three months to a year to be available for clinical trials.

WXXI's Veronica Volk spoke with a Rochester scientist who is working with a compound that fights coronavirus in a laboratory setting.

But Harold Smith, president and CEO of OyaGen, says the compound has been tested for safety in the 1960s, when it was being considered for use on cancer patients.

He is hoping this information will encourage the FDA to fast-track OYA1 for clinical testing in humans.

"When we are in a dire situation as we are at this time, with coronavirus, we cant be flat-footed and look at this as weve got an academic leisure approach to this," Smith said.

Smith is a tenured professor of biochemistry and biophysics at the University of Rochester.

He previously has worked on identifying compounds to treat the Ebola virus and MERS. Those compounds never went to trial, either, but he said they were also effective in laboratory settings.

Smith said he has been working with the federal government to develop these treatments.

Read more:
Rochester biotech company testing compound to treat coronavirus - WXXI News

Race Is Real, But It’s Not Genetic – SAPIENS

Please note that this article includes an image of human remains.

A friend of mine with Central American, Southern European, and West African ancestry is lactose intolerant. Drinking milk products upsets her stomach, and so she avoids them. About a decade ago, because of her low dairy intake, she feared that she might not be getting enough calcium, so she asked her doctor for a bone density test. He responded that she didnt need one because blacks do not get osteoporosis.

My friend is not alone. The view that black people dont need a bone density test is a longstanding and common myth. A 2006 study in North Carolina found that out of 531 African American and Euro-American women screened for bone mineral density, only 15 percent were African American womendespite the fact that African American women made up almost half of that clinical population. A health fair in Albany, New York, in 2000, turned into a ruckus when black women were refused free osteoporosis screening. The situation hasnt changed much in more recent years.

Meanwhile, FRAX, a widely used calculator that estimates ones risk of osteoporotic fractures, is based on bone density combined with age, sex, and, yes, race. Race, even though it is never defined or demarcated, is baked into the fracture risk algorithms.

Lets break down the problem.

First, presumably based on appearances, doctors placed my friend and others into a socially defined race box called black, which is a tenuous way to classify anyone.

Race is a highly flexible way in which societies lump people into groups based on appearance that is assumed to be indicative of deeper biological or cultural connections. As a cultural category, the definitions and descriptions of races vary. Color lines based on skin tone can shift, which makes sense, but the categories are problematic for making any sort of scientific pronouncements.

Second, these medical professionals assumed that there was a firm genetic basis behind this racial classification, which there isnt.

Third, they assumed that this purported racially defined genetic difference would protect these women from osteoporosis and fractures.

The view that black people dont need a bone density test is a longstanding and common myth.

Some studies suggest that African American womenmeaning women whose ancestry ties back to Africamay indeed reach greater bone density than other women, which could be protective against osteoporosis. But that does not mean being blackthat is, possessing an outward appearance that is socially defined as blackprevents someone from getting osteoporosis or bone fractures. Indeed, this same research also reports that African American women are more likely to die after a hip fracture. The link between osteoporosis risk and certain racial populations may be due to lived differences such as nutrition and activity levels, both of which affect bone density.

But more important: Geographic ancestry is not the same thing as race. African ancestry, for instance, does not tidily map onto being black (or vice versa). In fact, a 2016 study found wide variation in osteoporosis risk among women living in different regions within Africa. Their genetic risks have nothing to do with their socially defined race.

When medical professionals or researchers look for a geneticcorrelateto race, they are falling into a trap: They assume thatgeographic ancestry, which does indeed matter to genetics, can be conflated with race, which does not. Sure, different human populations living in distinct places may statistically have different genetic traitssuch as sickle cell trait (discussed below)but such variation is about local populations (people in a specific region), not race.

Like a fish in water, weve all been engulfed by the smog of thinking that race is biologically real. Thus, it is easy to incorrectly conclude that racial differences in health, wealth, and all manner of other outcomes are the inescapable result of genetic differences.

The reality is that socially defined racial groups in the U.S. and most everywhere else do differ in outcomes. But thats not due to genes. Rather, it is due to systemic differences in lived experience and institutional racism.

Communities of color in the United States, for example, often have reduced access to medical care, well-balanced diets, and healthy environments. They are often treated more harshly in their interactions with law enforcement and the legal system. Studies show that they experience greater social stress, including endemic racism, that adversely affects all aspects of health. For example, babies born to African American women are more than twice as likely to die in their first year than babies born to non-Hispanic Euro-American women.

Systemic racism leads to different health outcomes for various populations. The infant mortality rate, for example, for African American infants is double that for European Americans. Kelly Lacy/Pexels

As a professor of biological anthropology, I teach and advise college undergraduates. While my students are aware of inequalities in the life experiences of different socially delineated racial groups, most of them also think that biological races are real things. Indeed, more than half of Americans still believe that their racial identity is determined by information contained in their DNA.

For the longest time, Europeans thought that the sun revolved around the Earth. Their culturally attuned eyes saw this as obvious and unquestionably true. Just as astronomers now know thats not true, nearly all population geneticists know that dividing people into races neither explains nor describes human genetic variation.

Yet this idea of race-as-genetics will not die. For decades, it has been exposed to the sunlight of facts, but, like a vampire, it continues to suck bloodnot only surviving but causing harm in how it can twist science to support racist ideologies. With apologies for the grisly metaphor, it is time to put a wooden stake through the heart of race-as-genetics. Doing so will make for better science and a fairer society.

In 1619, the first people from Africa arrived in Virginia and became integrated into society. Only after African and European bond laborers unified in various rebellions did colony leaders recognize the need to separate laborers. Race divided indentured Irish and other Europeans from enslaved Africans, and reduced opposition by those of European descent to the intolerable conditions of enslavement. What made race different from other prejudices, including ethnocentrism (the idea that a given culture is superior), is that it claimed that differences were natural, unchanging, and God-given. Eventually, race also received the stamp of science.

Swedish taxonomist Carl Linnaeus divided humanity up into racial categories according to his notion of shared essences among populations, a concept researchers now recognize has no scientific basis. Wikimedia Commons

Over the next decades, Euro-American natural scientists debated the details of race, asking questions such as how often the races were created (once, as stated in the Bible, or many separate times), the number of races, and their defining, essential characteristics. But they did not question whether races were natural things. They reified race, making the idea of race real by unquestioning, constant use.

In the 1700s, Carl Linnaeus, the father of modern taxonomy and someone not without ego, liked to imagine himself as organizing what God created. Linnaeus famously classified our own species into races based on reports from explorers and conquerors.

The race categories he created included Americanus, Africanus, and even Monstrosus (for wild and feral individuals and those with birth defects), and their essential defining traits included a biocultural mlange of color, personality, and modes of governance. Linnaeus described Europeaus as white, sanguine, and governed by law, and Asiaticus as yellow, melancholic, and ruled by opinion. These descriptions highlight just how much ideas of race are formulated by social ideas of the time.

In line with early Christian notions, these racial types were arranged in a hierarchy: a great chain of being, from lower forms to higher forms that are closer to God. Europeans occupied the highest rungs, and other races were below, just above apes and monkeys.

So, the first big problems with the idea of race are that members of a racial group do not share essences, Linnaeus idea of some underlying spirit that unified groups, nor are races hierarchically arranged. A related fundamental flaw is that races were seen to be static and unchanging. There is no allowance for a process of change or what we now call evolution.

There have been lots of efforts since Charles Darwins time to fashion the typological and static concept of race into an evolutionary concept. For example, Carleton Coon, a former president of the American Association of Physical Anthropologists, argued in The Origin of Races (1962) that five races evolved separately and became modern humans at different times.

One nontrivial problem with Coons theory, and all attempts to make race into an evolutionary unit, is that there is no evidence. Rather, all the archaeological and genetic data point to abundant flows of individuals, ideas, and genes across continents, with modern humans evolving at the same time, together.

In this map, darker colors correspond to regions in which people tend to have darker skin pigmentation. Reproduced with permission from Dennis ONeil.

A few pundits such as Charles Murray of the American Enterprise Institute and science writers such as Nicholas Wade, formerly of The New York Times, still argue that even though humans dont come in fixed, color-coded races, dividing us into races still does a decent job of describing human genetic variation. Their position is shockingly wrong. Weve known for almost 50 years that race does not describe human genetic variation.

In 1972, Harvard evolutionary biologist Richard Lewontin had the idea to test how much human genetic variation could be attributed to racial groupings. He famously assembled genetic data from around the globe and calculated how much variation was statistically apportioned within versus among races. Lewontin found that only about 6 percent of genetic variation in humans could be statistically attributed to race categorizations. Lewontin showed that the social category of race explains very little of the genetic diversity among us.

Furthermore, recent studies reveal that the variation between any two individuals is very small, on the order of one single nucleotide polymorphism (SNP), or single letter change in our DNA, per 1,000. That means that racial categorization could, at most, relate to 6 percent of the variation found in 1 in 1,000 SNPs. Put simply, race fails to explain much.

In addition, genetic variation can be greater within groups that societies lump together as one race than it is between races. To understand how that can be true, first imagine six individuals: two each from the continents of Africa, Asia, and Europe. Again, all of these individuals will be remarkably the same: On average, only about 1 out of 1,000 of their DNA letters will be different. A study by Ning Yu and colleagues places the overall difference more precisely at 0.88 per 1,000.

The circles in this diagram represent the relative size and overlap in genetic variation in three human populations. The African population circle (blue) is largest because it contains the most genetic diversity. Genetic diversity in European (orange) and Asian (green) populations is a subset of the variation in Africa. Reproduced by permission of the American Anthropological Association.Adapted from the original, which appeared in the book RACE.Not for sale or further reproduction.

The researchers further found that people in Africa had less in common with one another than they did with people in Asia or Europe. Lets repeat that: On average, two individuals in Africa are more genetically dissimilar from each other than either one of them is from an individual in Europe or Asia.

Homo sapiens evolved in Africa; the groups that migrated out likely did not include all of the genetic variation that built up in Africa. Thats an example of what evolutionary biologists call the founder effect, where migrant populations who settle in a new region have less variation than the population where they came from.

Genetic variation across Europe and Asia, and the Americas and Australia, is essentially a subset of the genetic variation in Africa. If genetic variation were a set of Russian nesting dolls, all of the other continental dolls pretty much fit into the African doll.

What all these data show is that the variation that scientistsfrom Linnaeus to Coon to the contemporary osteoporosis researcherthink is race is actually much better explained by a populations location. Genetic variation is highly correlated to geographic distance. Ultimately, the farther apart groups of people are from one another geographically, and, secondly, the longer they have been apart, can together explain groups genetic distinctions from one another. Compared to race, those factors not only better describe human variation, they invoke evolutionary processes to explain variation.

Those osteoporosis doctors might argue that even though socially defined race poorly describes human variation, it still could be a useful classification tool in medicine and other endeavors. When the rubber of actual practice hits the road, is race a useful way to make approximations about human variation?

When Ive lectured at medical schools, my most commonly asked question concerns sickle cell trait. Writer Sherman Alexie, a member of the Spokane-Coeur dAlene tribes, put the question this way in a 1998 interview: If race is not real, explain sickle cell anemia to me.

In sickle cell anemia, red blood cells take on an unusual crescent shape that makes it harder for the cells to pass through small blood vessels. Mark Garlick/Science Photo Library/AP Images

OK! Sickle cell is a genetic trait: It is the result of an SNP that changes the amino acid sequence of hemoglobin, the protein that carries oxygen in red blood cells. When someone carries two copies of the sickle cell variant, they will have the disease. In the United States, sickle cell disease is most prevalent in people who identify as African American, creating the impression that it is a black disease.

Yet scientists have known about the much more complex geographic distribution of sickle cell mutation since the 1950s. It is almost nonexistent in the Americas, most parts of Europe and Asiaand also in large swaths of Northern and Southern Africa. On the other hand, it is common in West-Central Africa and also parts of the Mediterranean, Arabian Peninsula, and India. Globally, it does not correlate with continents or socially defined races.

In one of the most widely cited papers in anthropology, American biological anthropologist Frank Livingstone helped to explain the evolution of sickle cell. He showed that places with a long history of agriculture and endemic malaria have a high prevalence of sickle cell trait (a single copy of the allele). He put this information together with experimental and clinical studies that showed how sickle cell trait helped people resist malaria, and made a compelling case for sickle cell trait being selected for in those areas. Evolution and geography, not race, explain sickle cell anemia.

What about forensic scientists: Are they good at identifying race? In the U.S., forensic anthropologists are typically employed by law enforcement agencies to help identify skeletons, including inferences about sex, age, height, and race. The methodological gold standards for estimating race are algorithms based on a series of skull measurements, such as widest breadth and facial height. Forensic anthropologists assume these algorithms work.

Skull measurements are a longstanding tool in forensic anthropology. Internet Archive Book Images/Flickr

The origin of the claim that forensic scientists are good at ascertaining race comes from a 1962 study of black, white, and Native American skulls, which claimed an 8090 percent success rate. That forensic scientists are good at telling race from a skull is a standard trope of both the scientific literature and popular portrayals. But my analysis of four later tests showed that the correct classification of Native American skulls from other contexts and locations averaged about two incorrect for every correct identification. The results are no better than a random assignment of race.

Thats because humans are not divisible into biological races. On top of that, human variation does not stand still. Race groups are impossible to define in any stable or universal way. It cannot be done based on biologynot by skin color, bone measurements, or genetics. It cannot be done culturally: Race groupings have changed over time and place throughout history.

Science 101: If you cannot define groups consistently, then you cannot make scientific generalizations about them.

Wherever one looks, race-as-genetics is bad science. Moreover, when society continues to chase genetic explanations, it misses the larger societal causes underlying racial inequalities in health, wealth, and opportunity.

To be clear, what I am saying is that human biogenetic variation is real. Lets just continue to study human genetic variation free of the utterly constraining idea of race. When researchers want to discuss genetic ancestry or biological risks experienced by people in certain locations, they can do so without conflating these human groupings with racial categories. Lets be clear that genetic variation is an amazingly complex result of evolution and mustnt ever be reduced to race.

Similarly, race is real, it just isnt genetic. Its a culturally created phenomenon. We ought to know much more about the process of assigning individuals to a race group, including the category white. And we especially need to know more about the effects of living in a racialized world: for example, how a societys categories Race is real, it just isnt genetic. Its a culturally created phenomenon.and prejudices lead to health inequalities. Lets be clear that race is a purely sociopolitical construction with powerful consequences.

It is hard to convince people of the dangers of thinking race is based on genetic differences. Like climate change, the structure of human genetic variation isnt something we can see and touch, so it is hard to comprehend. And our culturally trained eyes play a trick on us by seeming to see race as obviously real. Race-as-genetics is even more deeply ideologically embedded than humanitys reliance on fossil fuels and consumerism. For these reasons, racial ideas will prove hard to shift, but it is possible.

Over 13,000 scientists have come together to formand publicizea consensus statement about the climate crisis, and that has surely moved public opinion to align with science. Geneticists and anthropologists need to do the same for race-as-genetics. The recent American Association of Physical Anthropologists Statement on Race & Racism is a fantastic start.

In the U.S., slavery ended over 150 years ago and the Civil Rights Law of 1964 passed half a century ago, but the ideology of race-as-genetics remains. It is time to throw race-as-genetics on the scrapheap of ideas that are no longer useful.

We can start by getting my friendand anyone else who has been deniedthat long-overdue bone density test.

Read the original post:
Race Is Real, But It's Not Genetic - SAPIENS

Customized diets based on genetics, and 4 other food marketing trends gaining traction in 2020 – Genetic Literacy Project

Food marketers, take note of these trends shaping the future of the food and beverage industry:

Hypercustomization: Customizing food products based on a persons unique biomarkers sounds like a pipe dream but in reality, its not far down the pipeline to fruition.

There are companies that analyze food allergies via at home blood kits.

Thanks to artificial intelligence, a persons biological information can be analyzed, paving the way for food and meal plans that are hyperspecific to their data dietary needs.

A restaurant serving 3D-printed sushi is slated to open this year, offering diners custom dishes based on their biodata, to be analyzed prior to their reservation.

[Editors note: Listen to Podcast: AI-powered nutrition devices could cut exploding obesity rates. Will FDA rules keep them off the market? to learn more.]

Disaster Farming: The planet can only grow enough fresh fruits and vegetables to feed two-thirds of the current global population. With this dire notion, companies have sprung into action to develop alternative farming methods.

Along with . indoor and vertical farming, gene editing has also served as a breakthrough to improve food production in a climate-changing world.

Read the original post

See original here:
Customized diets based on genetics, and 4 other food marketing trends gaining traction in 2020 - Genetic Literacy Project

Genomics took a long time to fulfil its promise – The Economist

Mar 12th 2020

THE ATOMIC bomb convinced politicians that physics, though not readily comprehensible, was important, and that physicists should be given free rein. In the post-war years, particle accelerators grew from the size of squash courts to the size of cities, particle detectors from the scale of the table top to that of the family home. Many scientists in other disciplines looked askance at the money devoted to this big science and the vast, impersonal collaborations that it brought into being. Some looked on in envy. Some made plans.

The idea that sequencing the whole human genome might provide biology with some big science of its own first began to take root in the 1980s. In 1990 the Human Genome Project was officially launched, quickly growing into a global endeavour. Like other fields of big science it developed what one of the programmes leaders, the late John Sulston, called a tradition of hyperbole. The genome was Everest; it was the Apollo programme; it was the ultimate answer to that Delphic injunction, know thyself. And it was also, in prospect, a cornucopia of new knowledge, new understanding and new therapies.

By the time the completion of a (rather scrappy) draft sequence was announced at the White House in 2000, even the politicians were drinking the Kool-Aid. Tony Blair said it was the greatest breakthrough since antibiotics. Bill Clinton said it would revolutionise the diagnosis, prevention and treatment of most, if not all, human diseases. In coming years, doctors increasingly will be able to cure diseases like Alzheimers, Parkinsons, diabetes and cancer by attacking their genetic roots.

Such hype was always going to be hard to live up to, and for a long time the genome project failed comprehensively, prompting a certain Schadenfreude among those who had wanted biology kept small. The role of genetics in the assessment of peoples medical futures continued to be largely limited to testing for specific defects, such as the BRCA1 and BRCA2 mutations which, in the early 1990s, had been found to be responsible for some of the breast cancers that run in families.

To understand the lengthy gap between the promise and the reality of genomics, it is important to get a sense of what a genome really is. Although sequencing is related to an older technique of genetic analysis called mapping, it produces something much more appropriate to the White House kitchens than to the Map Room: a recipe. The genes strung out along the genomes chromosomesbig molecules of DNA, carefully packedare descriptions of lifes key ingredients: proteins. Between the genes proper are instructions as to how those ingredients should be used.

If every gene came in only one version, then that first human genome would have been a perfect recipe for a person. But genes come in many varietiesjust as chilies, or olive oils, or tinned anchovies do. Some genetic changes which are simple misprints in the ingredients specification are bad in and of themselvesjust as a meal prepared with fuel oil instead of olive oil would be inedible. Others are problematic only in the context of how the whole dish is put together.

The most notorious of the genes with obvious impacts on health were already known before the genome was sequenced. Thus there were already tests for cystic fibrosis and Huntingtons disease. The role of genes in common diseases turned out to be a lot more involved than many had naively assumed. This made genomics harder to turn into useful insight.

Take diabetes. In 2006 Francis Collins, then head of genome research at Americas National Institutes of Health, argued that there were more genes involved in diabetes than people thought. Medicine then recognised three such genes. Dr Collins thought there might be 12. Today the number of genes with known associations to type-2 diabetes stands at 94. Some of these genes have variants that increase a persons risk of the disease, others have variants that lower that risk. Most have roles in various other processes. None, on its own, amounts to a huge amount of risk. Taken together, though, they can be quite predictivewhich is why there is now an over-the-counter genetic test that measures peoples chances of developing the condition.

In the past few years, confidence in sciences ability to detect and quantify such genome-wide patterns of susceptibility has increased to the extent that they are being used as the basis for something known as a polygenic risk score (PRS). These are quite unlike the genetic tests people are used to. Those single-gene tests have a lot of predictive value: a person who has the Huntingtons gene will get Huntingtons; women with a dangerous BRCA1 mutation have an almost-two-in-three chance of breast cancer (unless they opt for a pre-emptive mastectomy). But the damaging variations they reveal are rare. The vast majority of the women who get breast cancer do not have BRCA mutations. Looking for the rare dangerous defects will reveal nothing about the other, subtler but still possibly relevant genetic traits those women do have.

Polygenic risk scores can be applied to everyone. They tell anyone how much more or less likely they are, on average, to develop a genetically linked condition. A recently developed PRS for a specific form of breast cancer looks at 313 different ways that genomes vary; those with the highest scores are four times more likely to develop the cancer than the average. In 2018 researchers developed a PRS for coronary heart disease that could identify about one in 12 people as being at significantly greater risk of a heart attack because of their genes.

Some argue that these scores are now reliable enough to bring into the clinic, something that would make it possible to target screening, smoking cessation, behavioural support and medications. However, hope that knowing their risk scores might drive people towards healthier lifestyles has not, so far, been validated by research; indeed, so far things look disappointing in that respect.

Assigning a PRS does not require sequencing a subjects whole genome. One just needs to look for a set of specific little markers in it, called SNPs. Over 70,000 such markers have now been associated with diseases in one way or another. But if sequencing someones genome is not necessary in order to inspect their SNPs, understanding what the SNPs are saying in the first place requires that a lot of people be sequenced. Turning patterns discovered in the SNPs into the basis of risk scores requires yet more, because you need to see the variations in a wide range of people representative of the genetic diversity of the population as a whole. At the moment people of white European heritage are often over-represented in samples.

The first genome cost, by some estimates, $3bn

The need for masses of genetic information from many, many human genomes is one of the main reasons why genomic medicine has taken off rather slowly. Over the course of the Human Genome Project, and for the years that followed, the cost of sequencing a genome fell quicklyas quickly as the fall in the cost of computing power expressed through Moores law. But it was falling from a great height: the first genome cost, by some estimates, $3bn. The gap between getting cheaper quickly and being cheap enough to sequence lots of genomes looked enormous.

In the late 2000s, though, fundamentally new types of sequencing technology became available and costs dropped suddenly (see chart). As a result, the amount of data that big genome centres could produce grew dramatically. Consider John Sulstons home base, the Wellcome Sanger Institute outside Cambridge, England. It provided more sequence data to the Human Genome Project than any other laboratory; at the time of its 20th anniversary, in 2012, it had produced, all told, almost 1m gigabytesone petabyteof genome data. By 2019, it was producing that same amount every 35 days. Nor is such speed the preserve of big-data factories. It is now possible to produce billions of letters of sequence in an hour or two using a device that could easily be mistaken for a chunky thumb drive, and which plugs into a laptop in the same way. A sequence as long as a human genome is a few hours work.

As a result, thousands, then tens of thousands and then hundreds of thousands of genomes were sequenced in labs around the world. In 2012 David Cameron, the British prime minister, created Genomics England, a firm owned by the government, and tasked initially with sequencing 100,000 genomes and integrating sequencing, analysis and reporting into the National Health Service. By the end of 2018 it had finished the 100,000th genome. It is now aiming to sequence five million. Chinas 100,000 genome effort started in 2017. The following year saw large-scale projects in Australia, America and Turkey. Dubai has said it will sequence all of its three million residents. Regeneron, a pharma firm, is working with Geisinger, a health-care provider, to analyse the genomes of 250,000 American patients. An international syndicate of investors from America, China, Ireland and Singapore is backing a 365m ($405m) project to sequence about 10% of the Irish population in search of disease genes.

Genes are not everything. Controls on their expressionepigentics, in the jargonand the effects of the environment need to be considered, too; the kitchen can have a distinctive effect on the way a recipe turns out. That is why biobanks are being funded by governments in Britain, America, China, Finland, Canada, Austria and Qatar. Their stores of frozen tissue samples, all carefully matched to clinical information about the person they came from, allow study both by sequencing and by other techniques. Researchers are keen to know what factors complicate the lines science draws from genes to clinical events.

Today various companies will sequence a genome commercially for $600-$700. Sequencing firms such as Illumina, Oxford Nanopore and Chinas BGI are competing to bring the cost down to $100. In the meantime, consumer-genomics firms will currently search out potentially interesting SNPs for between $100 and $200. Send off for a home-testing kit from 23andMe, which has been in business since 2006, and you will get a colourful box with friendly letters on the front saying Welcome to You. Spit in a test tube, send it back to the company and you will get inferences as to your ancestry and an assessment of various health traits. The health report will give you information about your predisposition to diabetes, macular degeneration and various other ailments. Other companies offer similar services.

Plenty of doctors and health professionals are understandably sceptical. Beyond the fact that many gene-testing websites are downright scams that offer bogus testing for intelligence, sporting ability or wine preference, the medical profession feels that people are not well equipped to understand the results of such tests, or to deal with their consequences.

An embarrassing example was provided last year by Matt Hancock, Britains health minister. In an effort to highlight the advantages of genetic tests, he revealed that one had shown him to be at heightened risk of prostate cancer, leading him to get checked out by his doctor. The test had not been carried out by Britains world-class clinical genomics services but by a private company; critics argued that Mr Hancock had misinterpreted the results and consequently wasted his doctors time.

23andMe laid off 14% of its staff in January

He would not be the first. In one case, documented in America, third-party analysis of genomic data obtained through a website convinced a woman that her 12-year-old daughter had a rare genetic disease; the girl was subjected to a battery of tests, consultations with seven cardiologists, two gynaecologists and an ophthalmologist and six emergency hospital visits, despite no clinical signs of disease and a negative result from a genetic test done by a doctor.

At present, because of privacy concerns, the fortunes of these direct-to-consumer companies are not looking great. 23andMe laid off 14% of its staff in January; Veritas, which pioneered the cheap sequencing of customers whole genomes, stopped operating in America last year. But as health records become electronic, and health advice becomes more personalised, having validated PRS scores for diabetes or cardiovascular disease could become more useful. The Type 2 diabetes report which 23andMe recently launched looks at over 1,000 SNPs. It uses a PRS based on data from more than 2.5m customers who have opted to contribute to the firms research base.

As yet, there is no compelling reason for most individuals to have their genome sequenced. If genetic insights are required, those which can be gleaned from SNP-based tests are sufficient for most purposes. Eventually, though, the increasing number of useful genetic tests may well make genome sequencing worthwhile. If your sequence is on file, many tests become simple computer searches (though not all: tests looking at the wear and tear the genome suffers over the course of a lifetime, which is important in diseases like cancer, only make sense after the damage is done). If PRSs and similar tests come to be seen as valuable, having a digital copy of your genome at hand to run them on might make sense.

Some wonder whether the right time and place to do this is at birth. In developed countries it is routine to take a pinprick of blood from the heel of a newborn baby and test it for a variety of diseases so that, if necessary, treatment can start quickly. That includes tests for sickle-cell disease, cystic fibrosis, phenylketonuria (a condition in which the body cannot break down phenylalanine, an amino acid). Some hospitals in America have already started offering to sequence a newborns genome.

Sequencing could pick up hundreds, or thousands, of rare genetic conditions. Mark Caulfield, chief scientist at Genomics England, says that one in 260 live births could have a rare condition that would not be spotted now but could be detected with a whole-genome sequence. Some worry, though, that it would also send children and parents out of the hospital with a burden of knowledge they might be better off withoutespecially if they conclude, incorrectly, that genetic risks are fixed and predestined. If there is unavoidable suffering in your childs future do you want to know? Do you want to tell them? If a child has inherited a worrying genetic trait, should you see if you have it yourselfor if your partner has? The ultimate answer to the commandment know thyself may not always be a happy one.

This article appeared in the Technology Quarterly section of the print edition under the headline "Welcome to you"

View post:
Genomics took a long time to fulfil its promise - The Economist

Can You Add 15 Years To Your Life? Q&A With Bisnow Escape Speaker David Sinclair, Genetics And Longevity Expert – Bisnow

Courtesy of David Sinclair

In the search for the fabled fountain of youth, no one may be closer than David Sinclair. A tenured professor of genetics at Harvard Medical School, Sinclair has published over 190 scientific papers and has co-founded a dozen biotechnology companies, many of which aim to answer the ancient question of why humans age, and to see if we can slow, or even reverse, the aging process.

The search has taken Sinclair deep into the world of genes and the microscopic molecules that delay aging, as well into the macroscopic ways in which each of us can extend our own lives, which range from the simple sitting less and eating more olive oil to the complex, like a carefully formulated cocktail of nutritional supplements that Sinclair takes each day.

Sinclair is among the scientists, behaviorists, designers and thinkers speaking at Bisnows Escape conference April 20-22 in Miami. He gave us a preview of what attendees will get to hear at his talk, as well as a few tips.

Apply hereto attend Escape 2020, April 20-22 at the 1 Hotel South Beach in Miami.

Bisnow: Can you give us a sense of what youll be talking about at Escape?

David Sinclair:The main message is that we now have enough knowledge about aging and genetics to add 15 or 20 years to our lives. The current optimistic view is that about 80% of the aging process is under our control.

Ill go through what we know about aging and then explain how to turn on our bodys natural defenses against disease and aging. Ill dive into the latest research and breakthroughs from my lab, where we are working to reprogram cells to be young again.

Then, Ill go through the top five habits that I would recommend we all implement immediately. My goal is for everyone to leave with a road map for how to extend the healthy periods of their lives.

Bisnow: Some real estate titans still head up their firms well into their 70s and 80s. Do you see longevity changing how long people work?

Sinclair:No question. We generally look at our parents generation as a guide of what our lives will be like, but that is completely wrong. Were living longer than any generation has ever lived before. My father went into a new career in his 70s, now hes in his 80s feeling like hes 30 again. If youre doing all the right things, you shouldnt expect to have to slow down. We could be making business decisions and playing tennis into our 90s.

Bisnow: This is, after all, a real estate conference. Do you see new real estate investment opportunities given how long you expect coming generations to live?

Sinclair:I know of a few groups, especially one in the U.K., that are building entirely different sorts of assisted-living and senior-living communities that allow people to be active with their bodies. No one wants to be shoved into a building where they will sit and be lonely. Even as they grow older, people are still very interested in living normal, active lives.

Bisnow: Say Im not ready to start taking a full supplement regimen. What are some of the simple things I can do to extend my life?

Sinclair:One of the biggest ones is to eat less often. You dont want to be hungry all the time, but the idea that we all need three large meals a day is false. Just moving is important. Try not to sit down too much. There are exercises to strengthen your hips and legs that take five minutes that can give you more muscle that burns energy and will keep you stable as you age.

Consuming red wine and olive oil that might sound obvious, but we now know exactly why they work. The last thing is temperature changes. Taking a sauna and cold plunge a few times a week can greatly reduce your rate of cardiovascular deterioration.

Bisnow: So how much longer could a 45- or 50-year-old who makes these changes expect to live?

Sinclair:We always have to go back to the data here. The data says if you do five central things dont smoke, get reasonable exercise, dont overeat, eat mostly plant-based foods and keep your microbiome healthy its been shown to give you an extra 14 years of life.

If you start doing the things that I do the supplements, skipping breakfast, having a late lunch I think 20 extra years is totally reasonable.

Apply hereto attend Escape 2020, April 20-22 at the 1 Hotel South Beach in Miami.

More:
Can You Add 15 Years To Your Life? Q&A With Bisnow Escape Speaker David Sinclair, Genetics And Longevity Expert - Bisnow

Connecting with NC Cooperative Extension – Gaston Gazette

What is NC Cooperative Extension?

We are more than cows and corn.

NC Cooperative Extension is Randolphs Countys link to the two land-grant universities in North Carolina (NC State and NC A&T). Land-grant universities have three parts to their mission: education, research and extension. NC Cooperative Extension extends research-based knowledge to all North Carolinians, helping them transform science into everyday solutions that improve their lives and grow our state.

Why Cooperative Extension?

Essential to extensions mission to grow the state is our collaboration with the US Department of Agricultures National Institute of Food and Agriculture (USDA-NIFA), NC State University, NC A&T State University and local (county) governments across the state. This strategic partnership and cooperation are why it is called Cooperative Extension.

Statewide, our funding is 14% federal, 36% state, 25% county and 25% other (grants, contracts donations etc). It is truly a cooperative effort to offer our services to North Carolina residents.

History of success: Then and now

In 1909, information was shared through a Boys Corn Club (the beginnings of 4-H) in Ashokie, NC, that adding nutrients to your cornfield by spreading manure could increase the corn yield. A young boy took that information when the average yield was 18 bushels per acre and increased his yield to 196 bushels per acre in two years. NC Cooperative Extension is still researching ways to increase farm productivity as the worlds population increases and with its demand for food.

Currently, agriculture is North Carolinas largest industry, generating $91.8 billion annually while employing roughly 17 percent of the states workforce. Ours is the third most diverse agriculture economy in the country, with more than 80 commercial crops and a large animal agriculture presence.

Another example from the early 1900s happened through Girls Canning Clubs. Young girls were taught food preservation. These girls sold their canned food in the wintertime to earn money. NC Cooperative Extension is still teaching life skills that build capacity in people. n 2019, 47,041 North Carolina consumers increased their knowledge of safe home food handling, preservation or preparation practices.

The Randolph County Center is fully staffed and offers services in all the NC Cooperative Extension program areas.

Adam Lawing is the Livestock Agent. Did you know that Randolph County has more beef cows and goats than any other county in North Carolina? Adam is a great resource for our Randolph County producers.

Blake Szilvay is the Field Crops/Forestry Agent. Blake helps producers identify pests and diseases in crops. He is a licensed drone pilot and uses that technology to help farmers. Blake has also brought forestry programming back to Randolph County to help woodland owners improve management practices. Over 50% of Randolph County is forested, and in 2016, those forested acres provided $4.6 million through harvests.

Ben Grandon is the Horticulture Agent. In 2019, Ben conducted 226 on-site consultations with homeowners. He helps with gardening questions, landscaping and lawn issues, and many more. Ben also leads the Randolph County Master Gardener Volunteer educational group. After Bens training, a Master Gardener Volunteer can provide research-based information about gardening and environmental stewardship to individuals. This years Master Gardener Training Course begins in April.

Jeannie Leonard is the Family and Consumer Sciences Agent. Jeannie can teach food preservation and cooking skills. Recently, her Cooking Under Pressure (Instant Pot) classes have been popular. Her next class is on March 26. Jeannie also works with Randolph County businesses and organizations when they want to offer their employees wellness programs. Jeannie provides training on healthy recipes and cooking tips on location or here at the office.

Allison Walker is the 4-H Agent. Allison is passionate about Randolph County youth. Currently, she is working with 60+ classrooms on the Embryology Project. Allison provides 1 dozen eggs and incubators to each classroom so the teachers can teach the provided embryology curriculum. The second graders learn firsthand about chick development and get to see the chicks emerge from their shells. 4-H is a great youth development program open to all youth, not just farm kids.

Jody Terry is the 4-H Program Assistant. Jody spends many days in afterschool programming. She helps children through character education, healthy lifestyle choices or STEM education. She is gearing up for Bike Safety Week where she helps teach bike safety to the fourth graders. Jody has worked with thousands of children in Randolph County through the years and still remains committed and passionate about 4-H programming for the children.

Contact us by calling 336-318-6000 or visiting https://randolph.ces.ncsu.edu/

Go here to read the rest:
Connecting with NC Cooperative Extension - Gaston Gazette